Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $153.2400 (1.32%) ($150.1650 - $153.5900) on Tue. Dec. 12, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.11% (three month average) | RSI | 91 | Latest Price | $153.2400(1.32%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV advances 1.2% a day on average for past five trading days. | Weekly Trend | ABBV advances 4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) IBB(65%) XLI(64%) XAR(60%) XLV(60%) VYM(59%) | Factors Impacting ABBV price | ABBV will decline at least -0.555% in a week (0% probabilities). GLD(-57%) VXX(-51%) BNDX(-46%) VIXM(-41%) XLE(-36%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.555% (StdDev 1.11%) | Hourly BBV | 1.5 () | Intraday Trend | 1% | | | |
|
5 Day Moving Average | $149.62(2.42%) | 10 Day Moving Average | $146.37(4.69%) | 20 Day Moving Average | $142.52(7.52%) | To recent high | -0.9% | To recent low | 11.4% | Market Cap | $270.359b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |